Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, dental products and immunoglobulins to the Nordic market.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.


Our ETEC-story is told in ”European Biotechnology”

2015-11-18

In the editorial hardback book ”European Biotechnology” we tell our story and describe our role within the life science/ biotech industry. What makes us unique, what is our goals and research collaborations? We tell the story about the ETEC vaccine that will be an important tool to battle diarrheal disease. http://www.hornonline.com/books/european_biotechnology/#204         […]

ETVAX® was presented at ASTMH in Philadelphia

2015-11-01

This week the 64th meeting of ASTMH (American Society of Tropical Medicine and Hygiene) was held in Philadelphia, USA. The annual meeting was a five-day educational conference that drew approximately 4,400 attendees. Our ETEC vaccine Etvax® was of cause on the agenda. Professor Svennerholm gave a talk about the great properties and development achievements of […]

Scandinavian Biopharma expands its product portfolio with an immunosuppressive drug

2015-10-29

Scandinavian Biopharma recently entered into a distribution agreement with Neovii Pharmaceuticals AG, a fully integrated global biopharmaceutical organization based in Switzerland, and has expanded its product offering to include Neovii’s GRAFALON®. “With GRAFALON® we offer an immunosuppressive drug with a proven track record that is well established in the hospital market. This product is unique […]